🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kiran Kumar Reddi

ORCID: 0000-0003-3166-1293

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability”.

ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability

Cell Death and Disease(2024)10.1038/s41419-024-06831-2

N/A

0.329DataRank · unranked

7 citations

Suresh Chava, Siva Chander Chabattula, Yvonne J. K. Edwards, Kamaljeet Singh, Romi Gupta +1 more

The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis

Cancers(2021)10.3390/cancers13215516

N/A

0DataRank · unranked

32 citations

Suresh Chava, Kiran Kumar Reddi, Romi Gupta, Lawrence David Mason

UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress

NAR Cancer(2022)10.1093/narcan/zcac035

N/A

0DataRank · unranked

22 citations

Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Yvonne J. K. Edwards +3 more

PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102356

N/A

0DataRank · unranked

2 citations

Suresh Bugide, Roshan Dutta, Kiran Kumar Reddi, Yvonne J. K. Edwards, Kamaljeet Singh +3 more